Virus de la hepatitis C y hepatocarcinoma

Rosas, Fernando; Matijasevic, Eugenio; Sierra, Fernando; Botero, Rafael C; Chalem, Fernando.
Acta méd. colomb ; 17(6): 453-56, nov.-dic. 1992. ilus
Artículo en Español | LILACS | ID: lil-183250

Documentos relacionados

  1. Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
  2. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response.
  3. Reply to: "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response".
  4. Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents.
  5. A review of alcohol-pathogen interactions: New insights into combined disease pathomechanisms.
  6. A Potential Serum <i>N</i>-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis.
  7. Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful.
  8. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
  9. High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
  10. Impact of IL-27p28 (rs153109) and TNF-&#945; (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.